Philadelphia-based University of Pennsylvania Health System recorded an operating income of $102.3 million (3.3% operating margin) in the first quarter of fiscal 2026, up from an operating income of $49.3 million (1.7% margin) during the same period last year, according to its most recent financial report.
Penn Medicine recorded total operating revenue of $3.3 billion for the three months ended Sept. 30, up from $2.8 billion during the same quarter last year. Net patient service revenue was $2.8 billion, up from $2.4 billion. Other operating revenue totaled $514.6 million, up from $406.6 million.
Total operating expenses were $3.1 billion in the first quarter, up from $2.7 billion during the same period last year. Salaries, wages and benefits costs totaled $1.7 billion, up from $1.5 billion. Supply and service expenses were $1.3 billion, up from $1.1 billion.
Penn Medicine recorded a net income of $222.1 million in the first quarter, up from $188.2 million during the same period last year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
